Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular imaging as a tool for personalized and targeted anticancer therapy.

× No keyword cloud information.

13 in total

Review 1. Optical contrast agents and imaging systems for detection and diagnosis of cancer.

Authors: Mark C Pierce; David J Javier; Rebecca Richards-Kortum
Journal: Int J Cancer Date: 2008-11-01 Impact factor: 7.396

2. 68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.

Authors: Gabriela Kramer-Marek; Nalini Shenoy; Jurgen Seidel; Gary L Griffiths; Peter Choyke; Jacek Capala
Journal: Eur J Nucl Med Mol Imaging Date: 2011-04-20 Impact factor: 9.236

3. Development and preclinical studies of ⁶⁴Cu-NOTA-pertuzumab F(ab')₂ for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT.

Authors: Karen Lam; Conrad Chan; Raymond M Reilly
Journal: MAbs Date: 2016-11-04 Impact factor: 5.857

4. Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.

Authors: Bok-Nam Park; Jang-Hee Kim; Kwanjae Lee; So Hyun Park; Young-Sil An
Journal: Eur Radiol Date: 2014-12-11 Impact factor: 5.315

5. Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes.

Authors: Neil Vasdev; Peter N Dorff; James P O'Neil; Frederick T Chin; Stephen Hanrahan; Henry F VanBrocklin
Journal: Bioorg Med Chem Date: 2011-03-21 Impact factor: 3.641

6. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.

Authors: Sven H Hausner; David L Kukis; M Karen J Gagnon; Catherine E Stanecki; Riccardo Ferdani; John F Marshall; Carolyn J Anderson; Julie L Sutcliffe
Journal: Mol Imaging Date: 2009 Mar-Apr Impact factor: 4.488

7. Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.

Authors: Kristin McLarty; Bart Cornelissen; Deborah A Scollard; Susan J Done; Kathy Chun; Raymond M Reilly
Journal: Eur J Nucl Med Mol Imaging Date: 2008-08-19 Impact factor: 9.236

8. Feasibility evaluation of radioimmunoguided surgery of breast cancer.

Authors: Ananth Ravi; Raymond M Reilly; Claire M B Holloway; Curtis B Caldwell
Journal: Int J Mol Imaging Date: 2012-02-20

9. A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.

Authors: Conrad Chan; Deborah A Scollard; Kristin McLarty; Serena Smith; Raymond M Reilly
Journal: EJNMMI Res Date: 2011-08-17 Impact factor: 3.138

10. Visualization of molecular composition and functionality of cancer cells using nanoparticle-augmented ultrasound-guided photoacoustics.

Authors: Srivalleesha Mallidi; Seungsoo Kim; Andrei Karpiouk; Pratixa P Joshi; Konstantin Sokolov; Stanislav Emelianov
Journal: Photoacoustics Date: 2015-01-13